Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Evoclin approved for acne vulgaris

Oct. 27, 2004

Phase II study for Levulan Kerastick in acne

Oct. 27, 2004

Enrollment completed in phase II actinic keratosis study of Polyphenon E

Oct. 26, 2004

Therapeutic benefits of topical bimosiamose in psoriasis vulgaris

Oct. 25, 2004

Alefacept approved in Canada for chronic plaque psoriasis

Oct. 22, 2004

Cambrex to market and distribute Orcel

Oct. 20, 2004

UCB Pharma to discontinue Olux, Luxiq copromotion

Oct. 19, 2004

Phase II study set to open this month evaluating Zyflo for acne

Oct. 13, 2004

New androgen receptor antagonists in early development at Pfizer

Oct. 13, 2004

rHuEPO active in wound healing

Oct. 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...